Thymoquinone inhibits metastatic phenotype and epithelial‑mesenchymal transition in renal cell carcinoma by regulating the LKB1/AMPK signaling pathway

Bo Kou(First Affiliated Hospital of Xi'an Jiaotong University), Wei Liu(First Affiliated Hospital of Xi'an Jiaotong University)
Oncology Reports
June 25, 2018
10.3892/or.2018.6519
Cited by 24

Related Papers

Oridonin represses epithelial-mesenchymal transition and angiogenesis of thyroid cancer via downregulating JAK2/STAT3 signaling
|International Journal of Medical Sciences|2022|56
Autophagy induction enhances tetrandrine-induced apoptosis via the AMPK/mTOR pathway in human bladder cancer cells
|Oncology Reports|2017|47
Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1
|International Journal of Oncology|2016|37
HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway
|Oncology Reports|2017|24
<p>Oridonin Induces Apoptosis of Laryngeal Carcinoma via Endoplasmic Reticulum Stress</p>
|Cancer Management and Research|2020|18